Canada markets open in 4 hours 6 minutes

Nutrien Ltd. (NTR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
76.38+0.13 (+0.17%)
At close: 04:00PM EST
76.01 -0.37 (-0.48%)
After hours: 07:37PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close76.25
Bid76.14 x 800
Ask0.00 x 1200
Day's Range76.13 - 78.09
52 Week Range67.23 - 117.25
Avg. Volume2,265,829
Market Cap39.737B
Beta (5Y Monthly)0.83
PE Ratio (TTM)5.43
Earnings DateN/A
Forward Dividend & Yield1.92 (2.52%)
Ex-Dividend DateDec 29, 2022
1y Target EstN/A
  • Business Wire

    Nutrien Prices Offering of an Aggregate of US$1 Billion of 2-Year and 3-Year Senior Notes

    SASKATOON, Saskatchewan, November 07, 2022--Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$500 million aggregate principal amount of 5.900 percent senior notes due November 7, 2024 and US$500 million aggregate principal amount of 5.950 percent senior notes due November 7, 2025 (together, the "senior notes"). The offering is expected to close on or about November 9, 2022, subject to customary closing conditions. The senior notes, registered under the multi-jurisdictional discl

  • Business Wire

    Nutrien Declares Quarterly Dividend of US$0.48 per Share

    SASKATOON, Saskatchewan, November 03, 2022--Nutrien Ltd (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.48 per share payable on January 13, 2023, to shareholders of record on December 30, 2022.

  • Business Wire

    Nutrien Delivers Earnings Growth and Expects Strong Market Fundamentals in 2023

    SASKATOON, Saskatchewan, November 02, 2022--Nutrien Ltd. (TSX and NYSE: NTR) announced today its third quarter 2022 results, with net earnings of $1.6 billion ($2.94 diluted net earnings per share), which includes a non-cash impairment reversal of $330 million relating to our Phosphate operations. Third quarter 2022 adjusted net earnings per share1 were $2.51 and adjusted EBITDA1 was $2.5 billion.